Breadcrumb

What's New at the RI-MUHC ?

A Quebec first: Research chair in women's heart health

Heart & Stroke and McGill University to create Early-Career Professorship in Women’s Heart Health

$27.9M to develop novel therapeutics options for patients with cancer

RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline

Patient empowerment app Opal wins Prix d'excellence honour

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

Guidelines for managing anaphylaxis in children need an update

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

Canadian researchers on promising path towards developing flu treatment using lipid target

A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection

Widespread off-label use of epilepsy medications could put some patients at risk

Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

Children in Quebec are not diagnosed early enough with type 1 diabetes

A study reveals a rise in the number of children presenting a life-threatening complication at diagnosis.

The unanticipated early origins of childhood brain cancer

Canadian researchers identify earliest traces of brain cancer long before the disease becomes symptomatic

Learn more about the RI-MUHC